Down-regulation of PKHD1 induces cell apoptosis through PI3K and NF-κB pathways

Liping Sun1, Shixuan Wang, Chaofeng Hu

  • 1Division of Nephrology, Shenzhen People's Hospital, Second Clinical Medical College, Jinan University, Shenzhen 518020, China.

Insights

PKHD1 gene mutations cause ARPKD. Silencing PKHD1 in kidney cells increased PI3K/Akt activity, which, when inhibited, promoted apoptosis and increased NF-κB activity, suggesting a role in ARPKD pathogenesis.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Genetics

Background:

  • Autosomal recessive polycystic kidney disease (ARPKD) is caused by mutations in the PKHD1 gene.
  • Fibrocystin/polyductin (FPC), encoded by PKHD1, is a protein implicated in ARPKD pathogenesis.
  • The precise mechanisms regulating apoptosis in ARPKD cystogenesis remain unclear.

Purpose of the Study:

  • To investigate the interplay between apoptosis, phosphatidylinositol 3-kinase (PI3K)/Akt signaling, and nuclear factor κB (NF-κB) in kidney cells with reduced FPC expression.
  • To elucidate the role of FPC in regulating cell survival and death pathways relevant to ARPKD.

Main Methods:

  • Utilized PKHD1-silenced HEK293 cells to model FPC deficiency.
  • Administered PI3K/Akt inhibitors (LY294002, wortmannin) to assess their impact on apoptosis and proliferation.
  • Measured caspase-3 activity and NF-κB activation levels.

Main Results:

  • PKHD1 silencing led to elevated PI3K/Akt pathway activity in HEK293 cells.
  • Inhibition of PI3K/Akt significantly increased serum starvation-induced apoptosis.
  • PI3K/Akt inhibition resulted in decreased cell proliferation and enhanced NF-κB activity.

Conclusions:

  • The PI3K/Akt pathway plays a crucial role in regulating apoptosis in PKHD1-silenced kidney cells.
  • Inhibition of PI3K/Akt signaling correlates with increased NF-κB activity.
  • These findings offer insights into FPC function and potential therapeutic strategies for ARPKD.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.